Health
Eyepoint's Vision Treatment Trial Falls Short, Stock Takes a Hit
By Editor • August 17, 2026 • 1 min read
Eyepoint's experimental vision treatment trial fails to meet expectations, affecting its stock and plans for regulatory approval.
Read more